A Bioavailability Study Comparing Treprostinil Diethanolamine Oral Tablets and Oral Solution in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

August 31, 2010

Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG

treprostinil diethanolamine

Subjects will be administered a 1 mg dose of treprostinil diethanolamine as a single tablet, and treprostinil diethanolamine oral solution 0.25 mg dose every 2 hours for four doses (1 mg total).

Trial Locations (1)

78744

PPD Development, Austin

Sponsors
All Listed Sponsors
lead

United Therapeutics

INDUSTRY